Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

6.9K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
6.9K
Production of Formed Elements01:34

Production of Formed Elements

7.3K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
7.3K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Hematopoiesis01:21

Hematopoiesis

8.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.1K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
Source And Potency Of Stem Cells01:27

Source And Potency Of Stem Cells

5.0K
Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling Genetic Diversity in Sickle Cell Disease Reveals Heterogeneous Responses to HbF-Inducing Therapies.

bioRxiv : the preprint server for biology·2026
Same author

Hematopoietic JAK2V617F mutation-induced reprogramming of blood and bone marrow megakaryocytes.

Blood advances·2026
Same author

A heterozygous CEBPA mutation disrupting the bZIP domain in a RUNX1 and SRSF2 mutational background causes MDS disease progression.

Nature communications·2025
Same author

Breathing life into the hematopoietic potential of the lung.

Blood·2025
Same author

Abnormal global longitudinal strain and reduced serum inflammatory markers in cardiac AL amyloidosis patients without significant amyloid fibril deposition.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis·2025
Same author

The lung is a megakaryocyte outpost that can defend against thrombocytopenic attack.

The Journal of clinical investigation·2024

Related Experiment Video

Updated: Apr 27, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

19.4K

Stem cells, megakaryocytes, and platelets.

Brenden W Smith1, George J Murphy

  • 1aSection of Hematology and Oncology, Department of Medicine, Boston University School of Medicine bCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, Massachusetts, USA.

Current Opinion in Hematology
|July 16, 2014
PubMed
Summary

Stem cells enable the study and production of functional platelets. Research advances show stem cell-derived platelets are feasible for cellular therapy, offering revolutionary treatment for platelet disorders.

More Related Videos

Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors
14:30

Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors

Published on: August 7, 2021

6.9K
Isolation of Mouse Megakaryocyte Progenitors
10:30

Isolation of Mouse Megakaryocyte Progenitors

Published on: May 20, 2021

6.6K

Related Experiment Videos

Last Updated: Apr 27, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

19.4K
Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors
14:30

Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors

Published on: August 7, 2021

6.9K
Isolation of Mouse Megakaryocyte Progenitors
10:30

Isolation of Mouse Megakaryocyte Progenitors

Published on: May 20, 2021

6.6K

Area of Science:

  • Hematology
  • Stem Cell Biology
  • Cellular Therapy

Background:

  • Stem cells are crucial for studying megakaryopoiesis and producing functional platelets ex-vivo.
  • Understanding megakaryocyte and platelet differentiation is key for therapeutic applications.

Purpose of the Study:

  • To review the optimization of megakaryocyte and platelet differentiation from stem cells.
  • To discuss mechanistic studies and disease models utilizing stem cell technologies.
  • To highlight the potential of stem cell-derived platelets for clinical applications.

Main Methods:

  • Review of literature on stem cell differentiation protocols for megakaryocytes and platelets.
  • Analysis of studies investigating cytoskeletal regulation and signal transduction in hematopoiesis.
  • Examination of disease modeling and genetic correction using stem cell-derived cells.

Main Results:

  • Insights into hematopoietic stem cell and megakaryocyte lineage dynamics.
  • Successful modeling and genetic correction of platelet disorders.
  • Optimized differentiation strategies making stem cell-derived platelets viable for cellular therapy.

Conclusions:

  • Stem cell-derived megakaryocytes and platelets advance understanding of megakaryopoiesis.
  • These cells facilitate disease modeling and correction, paving the way for clinical translation.
  • Pluripotent stem cell-derived platelets offer revolutionary therapeutic potential for platelet-associated diseases.